Testing vision grids for glaucoma patients
Part of Eyes & vision clinical trials.
This trial compares different visual field test patterns to detect central vision loss in glaucoma patients who already show thinning of retinal cells. The goal is to find which test pattern works best for early detection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have glaucoma with an abnormal optic nerve head
- You have thinning of the inner retinal layer (ganglion cells)
- You are 18 years or older
- You can read and sign a consent form
- You are able to perform a visual field test
- Your glaucoma is not advanced (cup-to-disc ratio not more than 0.7)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at different ways to measure how glaucoma affects your vision over time by comparing visual field results. It may help researchers find better models to track progression so treatment decisions can be made more accurately.
This study tests new ways to diagnose glaucoma (and sometimes related eye conditions) using eye exams and measurements. It may help improve how doctors detect glaucoma earlier and more accurately.
This study uses a special imaging test (OCT angiography) to look at blood flow around the optic nerve in people with advanced glaucoma. It aims to better understand how glaucoma affects eye circulation, which may help improve future care.
This pilot study tests a new portable device for measuring your field of vision during a glaucoma clinic visit. You may benefit from a quicker or more convenient test.
This study tracks changes in blood flow, structure, and vision over time in people with glaucoma or high eye pressure. It aims to understand how these conditions progress, which could help improve future treatment.
This study measures how blood flows in the retina and how well the eye regulates that flow. It compares people with early or very early glaucoma to people without glaucoma to see what differences may predict progression.
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.